Rise and regional disparities in buprenorphine utilization in the United States.

Autor: Pashmineh Azar AR; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Cruz-Mullane A; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Podd JC; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Lam WS; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Kaleem SH; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Lockard LB; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Mandel MR; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Chung DY; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA., Simoyan OM; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.; Geisinger Marworth Treatment Center, Waverly, Pennsylvania, USA., Davis CS; Network for Public Health Law, Los Angeles, California, USA., Nichols SD; Department of Pharmacy Practice, University of New England, Portland, Maine, USA.; Department of Psychiatry, Tufts University, Medford, Massachusetts, USA., McCall KL; Department of Pharmacy Practice, University of New England, Portland, Maine, USA., Piper BJ; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.; Center for Pharmacy Innovation and Outcomes, Geisinger Precision Health Center, Forty Fort, Pennsylvania, USA.

Publikováno v: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Jun; Vol. 29 (6), pp. 708-715. Date of Electronic Publication: 2020 Mar 16.